Se-Jin Park
Directeur Financier/CFO chez LIGACHEM BIOSCIENCES INC.
Fortune : 9 M $ au 30/04/2024
Profil
Se-Jin Park is currently the Director at LegoChem Pharma, Inc. He is also a Non-Executive Director at BASKHANBIOPharma, Inc. and the Chief Operating & Financial Officer at LigaChem Biosciences, Inc. Previously, he worked as a Team Leader-Visual Materials at LG Chem Ltd.
from 2003 to 2006.
Dr. Park completed his undergraduate degree at Korea University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
01/04/2024 | 181 528 ( 0,50% ) | 9 M $ | 30/04/2024 |
Postes actifs de Se-Jin Park
Sociétés | Poste | Début |
---|---|---|
LIGACHEM BIOSCIENCES INC. | Directeur Financier/CFO | 15/09/2011 |
BASKHANBIO PHARMA INC. | Directeur/Membre du Conseil | 01/01/2016 |
LegoChem Pharma, Inc.
LegoChem Pharma, Inc. Pharmaceuticals: MajorHealth Technology LegoChem Pharma, Inc. manufactures pharmaceutical products. Its products include generic and prescription drugs, ophthalmic solvents, and ophthalmic surgical supplies. The company was founded in 1968 and is headquartered in Seoul, South Korea. | Directeur/Membre du Conseil | - |
Anciens postes connus de Se-Jin Park
Sociétés | Poste | Fin |
---|---|---|
LG CHEM, LTD. | Corporate Officer/Principal | 01/06/2006 |
Formation de Se-Jin Park
Korea University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
LIGACHEM BIOSCIENCES INC. | Health Technology |
LG CHEM, LTD. | Process Industries |
BASKHANBIO PHARMA INC. | Health Technology |
Entreprise privées | 1 |
---|---|
LegoChem Pharma, Inc.
LegoChem Pharma, Inc. Pharmaceuticals: MajorHealth Technology LegoChem Pharma, Inc. manufactures pharmaceutical products. Its products include generic and prescription drugs, ophthalmic solvents, and ophthalmic surgical supplies. The company was founded in 1968 and is headquartered in Seoul, South Korea. | Health Technology |